Can CDK4/6 inhibitors cause fatal lung injury?
2019
The CDK4/6 inhibitors – palbociclib, abemaciclib, and ribociclib – have been approved to be used with aromatase inhibitors/fulvestrant in the setting of advanced, hormone receptor-positive breast c...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
11
Citations
NaN
KQI